New drug IY-828026 tested in healthy people for first time
NCT ID NCT07433556
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests the safety of a new drug called IY-828026 in 86 healthy adults aged 19 to 50. Participants receive either the drug or a placebo to see how the body processes it and if any side effects occur. The goal is to gather important safety and dosing information, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALHTY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Hospital
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Morning larks vs night owls: does chronotype shape balance and brain power?
- New portable breath analyzer could bring Lab-Grade fitness testing to the field
- Inside the elite Athlete's body: hormones and brain chemicals measured during All-Out rowing
- Alzheimer's memory boost? study tests action and video tricks
- Your body shape may change how drugs work
- Breast Milk's hidden sugars: key to Baby's health?